Ohr Pharmaceutical, Inc. (NASDAQ: OHRP), an ophthalmology research and development company, today announced that it intends to offer shares of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE